Amantadine Dosing Considerations

Introduction to Amantadine Dosing

The Centers for Disease Control and Prevention recommends that for patients with impaired renal function, amantadine requires dose reduction when creatinine clearance is ≤50 mL/min, with specific adjustments based on the degree of renal impairment, and the daily dose should not exceed 100 mg in elderly patients (≥65 years) regardless of indication 1, 2, 3

For patients with creatinine clearance ≤50 mL/min, dose reduction is mandatory and must follow package insert guidelines based on specific creatinine clearance values, as recommended by the Centers for Disease Control and Prevention 1, 2, 3, 4
Close monitoring for adverse reactions is essential in patients with impaired renal function, as recommended dosages provide only approximations of optimal dosing, according to the Centers for Disease Control and Prevention 1, 2, 3

The Centers for Disease Control and Prevention recommends a maximum daily dose of 100 mg for elderly patients (≥65 years) for both prophylaxis and treatment, regardless of indication, due to the decline in renal function with age 1, 2, 3, 5, 6
Elderly women are at higher risk for side effects than elderly men at 100 mg daily due to smaller average body size, as noted by the Centers for Disease Control and Prevention 1, 6

The Centers for Disease Control and Prevention recommends a dose of 5 mg/kg/day (not to exceed 150 mg/day) for pediatric patients (1-9 years) to reduce toxicity risk 3, 5
For pediatric patients (>10 years), the standard dose is 200 mg/day (100 mg twice daily), as recommended by the Centers for Disease Control and Prevention 3, 5

Patients with creatinine clearance ≤50 mL/min require intensive monitoring, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
Elderly patients, particularly those ≥65 years, require close monitoring due to the risk of drug accumulation, according to the Centers for Disease Control and Prevention 1, 2, 3, 5

Amantadine is 90% excreted unchanged in urine via glomerular filtration and tubular secretion, as noted by the Centers for Disease Control and Prevention 1, 4

Mild CNS effects, such as nervousness, anxiety, insomnia, difficulty concentrating, and lightheadedness, occur in 5-14% of patients at 200 mg/day, according to the Centers for Disease Control and Prevention 4, 7, 8
Severe CNS effects, including marked behavioral changes, delirium, hallucinations, agitation, and seizures, are associated with high plasma concentrations, particularly in patients with renal insufficiency taking 200 mg/day, as reported by the Centers for Disease Control and Prevention 1, 2, 4, 7

The American Academy of Family Physicians recommends a standard adult dosing of 100 mg twice daily for influenza treatment/prophylaxis in adults (13-64 years) 9, 10, 11
For pediatric patients (1-9 years), the recommended dose is 5 mg/kg/day divided into two doses, not exceeding 150 mg/day 9, 10, 11
Pediatric patients (10-12 years) should receive 100 mg twice daily 9, 10, 11

The American Academy of Family Physicians and MMWR Recommendations and Reports suggest that elderly patients (≥65 years) should receive a maximum dose of 100 mg once daily (every 24 hours) due to age-related decline in renal function 9, 10, 12, 13
For patients with renal impairment (creatinine clearance ≤50 mL/min/1.73m²), dosing intervals must be extended significantly based on the degree of impairment 9, 10, 12
The Centers for Disease Control and Prevention (CDC) recommends consulting the drug package insert for specific interval recommendations based on creatinine clearance values 9, 10, 11, 12
For creatinine clearance ≤10 mL/min, the dose should be reduced to 100 mg once daily or less frequently 13

Hemodialysis does not significantly clear amantadine, so dosing intervals cannot be shortened based on dialysis schedules 12, 13
Failing to reduce dosing frequency in elderly patients leads to drug accumulation and CNS toxicity, as amantadine is 90% excreted unchanged in urine 13
Not consulting the package insert for renal dosing adjustments when creatinine clearance is ≤50 mL/min/1.73m² results in severe adverse effects from accumulation 9, 10, 12